Should Family Members Get Genetic Testing for MODY?
At a Glance
If genetic testing confirms a pathogenic or likely pathogenic MODY variant, parents, siblings, and children should consider targeted cascade testing. A positive result can identify inherited diabetes and guide subtype-specific treatment, while a negative result rules out only the family variant.
In this answer
4 sections
Yes. If you have been diagnosed with a specific Maturity-Onset Diabetes of the Young (MODY) subtype through genetic testing, your first-degree relatives—meaning your parents, siblings, and children—should strongly consider getting tested [1][2]. This targeted testing of family members for your exact genetic variant is known as cascade testing [3].
Because MODY is a genetic condition, a confirmed diagnosis in you often means that your close relatives are at high risk of carrying the same genetic variant. For many families, this testing provides life-changing answers. It allows relatives who were previously misdiagnosed with common Type 1 or Type 2 diabetes to receive more effective, targeted treatments based on their specific genetic makeup [4][5].
Correcting Misdiagnoses and Improving Treatment
One of the most vital reasons for cascade testing is that relatives who carry the MODY variant may currently be treating their diabetes inappropriately. Testing frequently uncovers MODY in relatives who were previously labeled with Type 1 or Type 2 diabetes [5][6].
Identifying the exact genetic subtype of MODY directly changes how the diabetes is managed and monitored [7][8]:
- HNF1A-MODY and HNF4A-MODY: People with these subtypes who are mistakenly thought to have Type 1 diabetes are often prescribed multiple daily insulin injections. Once correctly diagnosed with MODY, many can safely switch to oral medications called sulfonylureas under medical supervision. This often provides better blood sugar control, though careful dosing is required by a doctor to prevent hypoglycemia (low blood sugar) [9][10].
- GCK-MODY: People with this subtype typically have stable, mildly elevated blood sugars that are usually low risk for diabetes complications [9][11]. Outside of pregnancy, they generally do not need glucose-lowering medications and can often stop them once supervised by a doctor [9][11].
Important Safety Warning: NEVER stop taking insulin or change your diabetes medication without explicit instructions and close supervision from your diabetes care team. Abruptly stopping insulin is extremely dangerous if you or a relative actually have Type 1 diabetes or another insulin-dependent condition.
It is important to remember that not everyone in the family who has diabetes will necessarily have MODY. Relatives can sometimes develop regular Type 1 or Type 2 diabetes independently. Testing for your specific familial variant is the only way to distinguish these possibilities [12].
How MODY is Inherited
MODY is typically passed down through families in an autosomal dominant inheritance pattern [13]. This means that a person only needs to inherit one copy of the altered gene from one parent to have the condition.
- Children: If you carry a MODY mutation, there is a 50% chance of passing it on to each of your children [14][15].
- Siblings and Parents: Usually, the mutation was inherited from one of your parents, meaning your siblings also have a 50% chance of carrying it. However, sometimes the mutation is de novo (a brand-new mutation in you that your parents do not have). If it is a new mutation, your parents and siblings are not at high risk. Testing your parents can clarify this [1].
While the gene variant is passed down, the disease may look like it “skips” a generation. This happens due to reduced penetrance, meaning a person can carry the genetic mutation but never develop diabetes, or they may only develop it much later in life [16][14].
What the Results Mean
Cascade testing is only recommended if your original genetic test found a “pathogenic” or “likely pathogenic” variant [2]. It is generally not recommended if you only have a “variant of uncertain significance” (VUS) [1].
- A positive result: Identifies that the relative is a carrier of the familial variant. This prompts subtype-specific care, monitoring, and future family planning [16].
- A negative result: Rules out the familial variant. However, it does not mean the relative cannot develop regular Type 1 or Type 2 diabetes, or another unrelated cause of diabetes [12].
Next Steps: Genetic Counseling
Before your relatives arrange testing, it is highly recommended that you and your family consult a genetic counselor or a specialist in monogenic diabetes [16].
A genetic counselor can:
- Coordinate the right test: They ensure your relatives are tested specifically for the exact gene variant you were diagnosed with, which is more accurate and often less expensive than running a broad genetic panel.
- Provide a family letter: Telling family members about a hereditary diagnosis can be emotionally difficult. A counselor can write a clear, medically accurate letter for you to share with your relatives, taking the pressure off you to explain the complex genetics.
- Guide testing for children: Testing guidelines for children depend on the specific MODY subtype. Some variants require earlier monitoring than others, and a counselor can help you decide if and when to test minors [17][16].
- Discuss privacy and implications: They will talk through what a positive or negative result means for your relatives’ health, as well as complex issues like medical privacy and how results might affect life or disability insurance before testing is done [18].
Common questions in this guide
Should my parents, siblings, or children be tested for MODY?
What is cascade testing for MODY?
How likely is it that my children or siblings inherited MODY?
Can MODY testing correct a diabetes misdiagnosis?
What does a negative familial MODY test result mean?
Should relatives be tested if my result is a variant of uncertain significance?
When should a child be tested for a MODY variant?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my genetic result classified as a pathogenic/likely pathogenic variant, or is it a variant of uncertain significance (VUS)?
- 2.Do you suspect my MODY variant was inherited from a parent, or could it be a new (de novo) mutation?
- 3.Can you refer me to a genetic counselor to help coordinate cascade testing and provide a family letter explaining the results?
- 4.How should we manage a family member who tests negative for the MODY variant but still has elevated blood sugar?
- 5.If my children test positive for this specific variant, at what age should they begin clinical monitoring or treatment?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?
Kim SH
Diabetes & metabolism journal 2015; (39(6)):468-77 doi:10.4093/dmj.2015.39.6.468.
PMID: 26706916 - 2
Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.
Breidbart E, Deng L, Lanzano P, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(5)):633-638 doi:10.1515/jpem-2020-0501.
PMID: 33852230 - 3
Identification of monogenic diabetes in an Australian cohort using the Exeter maturity-onset diabetes of the young (MODY) probability calculator and next-generation sequencing gene panel testing.
De Sousa SMC, Wu KHC, Colclough K, et al.
Acta diabetologica 2024; (61(2)):181-188 doi:10.1007/s00592-023-02193-x.
PMID: 37812285 - 4
Case Report: Misdiagnosis of Maturity-Onset Diabetes of the Young as type 1, type 2 or gestational diabetes: insights from a Latin American tertiary center.
Ruiz-Urbaez R, Males-Maldonado D, Villagómez-Estrada MV, et al.
Frontiers in medicine 2025; (12()):1613877 doi:10.3389/fmed.2025.1613877.
PMID: 41020216 - 5
Phenotypic heterogeneity and polygenic risk scores in a family of maturity-onset diabetes of the young.
Chatchomchuan W, Thewjitcharoen Y, Nakasatien S, et al.
JCEM case reports 2026; (4(4)):luag001 doi:10.1210/jcemcr/luag001.
PMID: 41909158 - 6
Two siblings with a rare type of maturity-onset diabetes of the young (MODY).
Alhakim FR, AlKhayyat H
BMJ case reports 2023; (16(2)) doi:10.1136/bcr-2022-249362.
PMID: 36764736 - 7
How do I diagnose Maturity Onset Diabetes of the Young in my patients?
Colclough K, Patel K
Clinical endocrinology 2022; (97(4)):436-447 doi:10.1111/cen.14744.
PMID: 35445424 - 8
Monogenic Diabetes in Youth With Presumed Type 2 Diabetes: Results From the Progress in Diabetes Genetics in Youth (ProDiGY) Collaboration.
Todd JN, Kleinberger JW, Zhang H, et al.
Diabetes care 2021; doi:10.2337/dc21-0491.
PMID: 34362814 - 9
Approach to the Patient with MODY-Monogenic Diabetes.
Broome DT, Pantalone KM, Kashyap SR, Philipson LH
The Journal of clinical endocrinology and metabolism 2021; (106(1)):237-250 doi:10.1210/clinem/dgaa710.
PMID: 33034350 - 10
Treatment switch from multiple daily insulin injections to sulphonylureas in an African young adult diagnosed with HNF1A MODY: a case report.
Katte JC, Dehayem MY, Colclough K, Sobngwi E
Journal of medical case reports 2024; (18(1)):506 doi:10.1186/s13256-024-04850-3.
PMID: 39420387 - 11
Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment.
Zečević K, Volčanšek Š, Katsiki N, et al.
Progress in cardiovascular diseases 2024; (85()):14-25 doi:10.1016/j.pcad.2024.03.004.
PMID: 38513726 - 12
Antibody-Positive Type 1 Diabetes in a Family With a Pathogenic HNF1A-MODY Variant and Variable Age of Onset.
McCullough ME, Dye AM, Kandasamy B, et al.
JCEM case reports 2025; (3(11)):luaf229 doi:10.1210/jcemcr/luaf229.
PMID: 41064662 - 13
A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY.
Bishay RH, Greenfield JR
The Medical journal of Australia 2016; (205(10)):480-485 doi:10.5694/mja16.00458.
PMID: 27852188 - 14
HNF1A-Maturity-Onset Diabetes of the Young (MODY) in a Family With a Rare Silent Variant: Clinical Challenges and Variable Expressivity.
Carvalho R, Moreira B, Parente S
Cureus 2026; (18(6)):e111076 doi:10.7759/cureus.111076.
PMID: 42472134 - 15
Maturity-onset diabetes of the young as a model for elucidating the multifactorial origin of type 2 diabetes mellitus.
Horikawa Y
Journal of diabetes investigation 2018; (9(4)):704-712 doi:10.1111/jdi.12812.
PMID: 29406598 - 16
Maturity onset diabetes of the young and beyond: the changing face of single-gene diabetes.
Laver TW, Patel KA
European journal of endocrinology 2025; (193(3)):R25-R29 doi:10.1093/ejendo/lvaf172.
PMID: 40819284 - 17
[Maturity-onset diabetes of the young].
van der Tuin K, Hannema SE, Houdijk EC, et al.
Nederlands tijdschrift voor geneeskunde 2015; (159()):A9247.
PMID: 26374728 - 18
Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance.
Patel KA, Kettunen J, Laakso M, et al.
Nature communications 2017; (8(1)):888 doi:10.1038/s41467-017-00895-9.
PMID: 29026101
This page is for informational purposes only and does not constitute medical advice. A genetic counselor and diabetes specialist should guide family testing and any medication changes.
Get notified when new evidence is published on MODY.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.